Home › Leerink Swann Issues Q4 2016 Earnings Estimate for Regeneron Pharmaceuticals
 

Keywords :   


Leerink Swann Issues Q4 2016 Earnings Estimate for Regeneron Pharmaceuticals

2015-11-08 00:21:39| Biotech - Topix.net

Leerink Swann issued their Q4 2016 earnings per share estimates for Regeneron Pharmaceuticals in a report issued on Thursday, Zacks reports. Leerink Swann analyst J. Schwartz expects that the brokerage will post earnings of $2.79 per share for the quarter.

Tags: issues estimate earnings pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
29.09Hurricane Isaac Graphics
29.09Hurricane Isaac Forecast Discussion Number 13
29.09Tropical Storm Joyce Graphics
29.09Hurricane Isaac Wind Speed Probabilities Number 13
29.09Hurricane Isaac Public Advisory Number 13
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Tropical Storm Joyce Wind Speed Probabilities Number 7
29.09Tropical Storm Joyce Forecast Discussion Number 7
More »